Intact somatotroph responsiveness after continuous growth hormone releasing hormone infusion
Schulte, H.M.; Allolio, B.; Frohwein, U.S.; Benker, G.; Ohnhaus, E.E.
European Journal of Clinical Investigation 17(2 Part 2): A3
1987
ISSN/ISBN: 0014-2972
Accession: 028552693
PDF emailed within 1 workday: $29.90
Related References
Schulte, H.M.; Allolio, B.; Frohwein, U.S.; Benker, G.; Winkelman, W.; Reinwein, D. 1986: Sustained somatotroph responsiveness after continuous growth hormone releasing hormone infusion growth hormone response to different stress stimuli Clinical Research 34(2): 553APorter, T.E.; Piper, M.M.chelle 1995: Somatotroph responsiveness to growth hormone -releasing hormone and thyrotropin-releasing hormone during chick embryonic development Poultry Science 74(Suppl 1): 69
Webb, C.B.; Perisutti, G.; Vance, M.L.; Borges, J.L.C.; Evans, W.S.; Thorner, M.O.; Forhman, L.A. 1983: Human growth hormone releasing factor stimulated growth hormone secretion decreased growth hormone responsiveness after continuous infusion Clinical Research 31(4): 763A
Rosenbaum, M.; Leibel, R.L.; Gertner, J.M. 1989: Acute inhibition of somatotroph response to human growth hormone-releasing hormone 1-44 occurs following three hours but not one hour of growth hormone infusion Metabolism, Clinical and Experimental 38(6): 590-593
Gianotti, L.; Maccario, M.; Lanfranco, F.; Ramunni, J.; Di Vito, L.; Grottoli, S.; Muller, E.E.; Ghigo, E.; Arvat, E. 2000: Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor i on the somatotroph responsiveness to growth hormone-releasing hormone in humans Journal of Clinical Endocrinology and Metabolism 85(10): 3604-3608
Rosenbaum, M.; Loche, S.; Balzano, S.; Gertner, J.M. 1988: Short-term met-hGH infusion inhibits somatotroph response to growth hormone releasing hormone (1-44) Metabolism, Clinical and Experimental 37(2): 131-135
Gil-Ad, I.; Klinger, B.; Pertzelan, A.; Erster, B.; Silbergeld, A.; Talpaz, H.; Laron, Z. 1992: Growth hormone therapy in normal short children induces a transitory decrease in plasma growth hormone releasing hormone levels and in human growth hormone responsiveness to exogenous growth hormone releasing hormone Journal of Endocrinological Investigation 15(10): 735-739
Broglio, F.; Benso, A.; Gottero, C.; Vito, L.D.; Granata, R.; Arvat, E.; Bobbio, M.; Trevi, G.; Ghigo, E. 2001: Effect of digoxin on the somatotroph responsiveness to growth hormone-releasing hormone (GHRH) alone or combined with arginine in normal young volunteers Clinical Endocrinology 55(6): 755-758
Vance, M.L.; Kaiser, D.L.; Rivier, J.; Vale, W.; Thorner, M.O. 1986: Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH Journal of Clinical Endocrinology and Metabolism 62(3): 591-594
Davis, J.R.; Sheppard, M.C.; Shakespear, R.A.; Lynch, S.S.; Clayton, R.N. 1986: Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-hour infusion of GRF 1-29 amide in man Clinical Endocrinology 24(2): 135-140
Rittmaster, R.S.; Loriaux, D.L.; Merriam, G.R. 1987: Effect of continuous somatostatin and growth hormone-releasing hormone (GHRH) infusions on the subsequent growth hormone (GH) response to GHRH. Evidence for somatotroph desensitization independent of GH pool depletion Neuroendocrinology 45(2): 118-122
Renner, U.; Brockmeier, S.; Strasburger, C.J.; Lange, M.; Schopohl, J.; Müller, O.A.; von Werder, K.; Stalla, G.K. 1994: Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide Journal of Clinical Endocrinology and Metabolism 78(5): 1090-1096
Boizel, R.; Halimi, S.; Labat, F.; Cohen, R.; Bachelot, I. 1987: Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment Journal of Clinical Endocrinology and Metabolism 64(2): 304-308
Brain, C.; Hindmarsh, P.C.; Brook, C.G.; Matthews, D.R. 1988: Continuous subcutaneous growth hormone releasing factor analogue augments growth hormone secretion in normal male subjects with no desensitization of the somatotroph Clinical Endocrinology 28(5): 543-549
Vance, M.L.; Kaiser, D.L.; Martha, P.M.; Furlanetto, R.; Rivier, J.; Vale, W.; Thorner, M.O. 1989: Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy Journal of Clinical Endocrinology and Metabolism 68(1): 22-28